annual total liabilities:
$58.12B+$4.92B(+9.26%)Summary
- As of today (April 17, 2025), NVS annual total liabilities is $58.12 billion, with the most recent change of +$4.92 billion (+9.26%) on December 31, 2024.
- During the last 3 years, NVS annual total liabilities has fallen by -$5.85 billion (-9.15%).
- NVS annual total liabilities is now -18.27% below its all-time high of $71.11 billion, reached on December 31, 2020.
Performance
NVS Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$58.12B-$1.96B(-3.27%)Summary
- As of today (April 17, 2025), NVS quarterly total liabilities is $58.12 billion, with the most recent change of -$1.96 billion (-3.27%) on December 31, 2024.
- Over the past year, NVS quarterly total liabilities has increased by +$2.52 billion (+4.53%).
- NVS quarterly total liabilities is now -35.88% below its all-time high of $90.64 billion, reached on March 31, 2019.
Performance
NVS quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
NVS Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.3% | +4.5% |
| 3 y3 years | -9.2% | +1.0% |
| 5 y5 years | -7.5% | -16.8% |
NVS Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -9.2% | +9.3% | -21.9% | +9.3% |
| 5 y | 5-year | -18.3% | +9.3% | -22.6% | +9.3% |
| alltime | all time | -18.3% | +341.3% | -35.9% | +341.3% |
Novartis AG Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $58.12B(+9.3%) | $58.12B(-3.3%) |
| Sep 2024 | - | $60.08B(+8.1%) |
| Jun 2024 | - | $55.60B(+1.9%) |
| Mar 2024 | - | $54.58B(+2.6%) |
| Dec 2023 | $53.20B(-8.3%) | $53.20B(-28.6%) |
| Sep 2023 | - | $74.45B(+26.1%) |
| Jun 2023 | - | $59.05B(-1.7%) |
| Mar 2023 | - | $60.10B(+3.6%) |
| Dec 2022 | $58.03B(-9.3%) | $58.03B(+0.8%) |
| Sep 2022 | - | $57.57B(-3.9%) |
| Jun 2022 | - | $59.90B(-5.7%) |
| Mar 2022 | - | $63.51B(-0.7%) |
| Dec 2021 | $63.97B(-10.0%) | $63.97B(-0.5%) |
| Sep 2021 | - | $64.27B(-8.0%) |
| Jun 2021 | - | $69.89B(-1.8%) |
| Mar 2021 | - | $71.16B(+0.1%) |
| Dec 2020 | $71.11B(+13.2%) | $71.11B(-5.3%) |
| Sep 2020 | - | $75.12B(+7.5%) |
| Jun 2020 | - | $69.88B(-3.1%) |
| Mar 2020 | - | $72.12B(+14.8%) |
| Dec 2019 | $62.82B(-6.1%) | $62.82B(-0.9%) |
| Sep 2019 | - | $63.37B(-2.2%) |
| Jun 2019 | - | $64.79B(-28.5%) |
| Mar 2019 | - | $90.64B(+35.5%) |
| Dec 2018 | $66.87B(+13.6%) | $66.87B(+2.9%) |
| Sep 2018 | - | $64.97B(-0.3%) |
| Jun 2018 | - | $65.16B(+1.3%) |
| Mar 2018 | - | $64.31B(+9.3%) |
| Dec 2017 | $58.85B(+6.6%) | $58.85B(-6.0%) |
| Sep 2017 | - | $62.60B(-1.8%) |
| Jun 2017 | - | $63.77B(-0.9%) |
| Mar 2017 | - | $64.34B(+16.5%) |
| Dec 2016 | $55.23B(+1.5%) | $55.23B(-6.3%) |
| Sep 2016 | - | $58.94B(+0.1%) |
| Jun 2016 | - | $58.90B(-2.7%) |
| Mar 2016 | - | $60.56B(+11.3%) |
| Dec 2015 | $54.43B(-0.2%) | $54.43B(-3.0%) |
| Sep 2015 | - | $56.14B(-0.8%) |
| Jun 2015 | - | $56.58B(-3.3%) |
| Mar 2015 | - | $58.49B(+7.2%) |
| Dec 2014 | $54.54B(+5.3%) | $54.54B(+1.1%) |
| Sep 2014 | - | $53.95B(-2.3%) |
| Jun 2014 | - | $55.25B(+0.5%) |
| Mar 2014 | - | $55.00B(+6.2%) |
| Dec 2013 | $51.78B(-5.7%) | $51.78B(-1.2%) |
| Sep 2013 | - | $52.41B(+1.9%) |
| Jun 2013 | - | $51.44B(-4.5%) |
| Mar 2013 | - | $53.86B(-1.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $54.93B(+6.5%) | $54.93B(+1.7%) |
| Sep 2012 | - | $54.01B(-0.4%) |
| Jun 2012 | - | $54.25B(-3.5%) |
| Mar 2012 | - | $56.21B(+9.0%) |
| Dec 2011 | $51.56B(-3.7%) | $51.56B(-6.7%) |
| Sep 2011 | - | $55.24B(-6.1%) |
| Jun 2011 | - | $58.82B(-4.9%) |
| Mar 2011 | - | $61.88B(+15.6%) |
| Dec 2010 | $53.55B(+40.8%) | $53.55B(-8.3%) |
| Sep 2010 | - | $58.41B(+42.1%) |
| Jun 2010 | - | $41.11B(+1.3%) |
| Mar 2010 | - | $40.58B(+6.7%) |
| Dec 2009 | $38.04B(+36.5%) | $38.04B(+1.8%) |
| Sep 2009 | - | $37.37B(+10.6%) |
| Jun 2009 | - | $33.79B(+6.4%) |
| Mar 2009 | - | $31.74B(+13.9%) |
| Dec 2008 | $27.86B(+6.9%) | $27.86B(-10.9%) |
| Sep 2008 | - | $31.28B(-1.6%) |
| Jun 2008 | - | $31.79B(+17.5%) |
| Mar 2008 | - | $27.05B(+3.8%) |
| Dec 2007 | $26.06B(-2.5%) | $26.06B(-5.1%) |
| Sep 2007 | - | $27.44B(+1.8%) |
| Jun 2007 | - | $26.96B(-3.1%) |
| Mar 2007 | - | $27.82B(+4.1%) |
| Dec 2006 | $26.71B(+8.7%) | $26.71B(-5.5%) |
| Sep 2006 | - | $28.27B(-1.7%) |
| Jun 2006 | - | $28.77B(+14.6%) |
| Mar 2006 | - | $25.09B(+2.1%) |
| Dec 2005 | $24.57B(+16.0%) | $24.57B(+7.1%) |
| Sep 2005 | - | $22.93B(+1.2%) |
| Jun 2005 | - | $22.65B(+12.2%) |
| Mar 2005 | - | $20.18B(-4.7%) |
| Dec 2004 | $21.17B(+12.6%) | $21.17B(+15.0%) |
| Sep 2004 | - | $18.41B(+0.1%) |
| Jun 2004 | - | $18.39B(-2.9%) |
| Mar 2004 | - | $18.94B(+0.8%) |
| Dec 2003 | $18.80B(+12.6%) | $18.80B(+5.1%) |
| Sep 2003 | - | $17.89B(-6.9%) |
| Jun 2003 | - | $19.22B(+3.1%) |
| Mar 2003 | - | $18.65B(+11.7%) |
| Dec 2002 | $16.69B(+13.2%) | $16.69B(+9.4%) |
| Sep 2002 | - | $15.25B(+0.7%) |
| Jun 2002 | - | $15.14B(+2.7%) |
| Dec 2001 | $14.75B(+12.0%) | $14.75B(+5.9%) |
| Jun 2001 | - | $13.92B(+5.7%) |
| Dec 2000 | $13.17B(-25.3%) | $13.17B(-15.5%) |
| Jun 2000 | - | $15.58B |
| Dec 1999 | $17.64B(-1.5%) | - |
| Dec 1998 | $17.90B | - |
FAQ
- What is Novartis AG annual total liabilities?
- What is the all time high annual total liabilities for Novartis AG?
- What is Novartis AG annual total liabilities year-on-year change?
- What is Novartis AG quarterly total liabilities?
- What is the all time high quarterly total liabilities for Novartis AG?
- What is Novartis AG quarterly total liabilities year-on-year change?
What is Novartis AG annual total liabilities?
The current annual total liabilities of NVS is $58.12B
What is the all time high annual total liabilities for Novartis AG?
Novartis AG all-time high annual total liabilities is $71.11B
What is Novartis AG annual total liabilities year-on-year change?
Over the past year, NVS annual total liabilities has changed by +$4.92B (+9.26%)
What is Novartis AG quarterly total liabilities?
The current quarterly total liabilities of NVS is $58.12B
What is the all time high quarterly total liabilities for Novartis AG?
Novartis AG all-time high quarterly total liabilities is $90.64B
What is Novartis AG quarterly total liabilities year-on-year change?
Over the past year, NVS quarterly total liabilities has changed by +$2.52B (+4.53%)